Holen Sie sich die Stockscreener-App
22.51
0.63%
0.14
Schlusskurs vom Vortag:
$22.37
Offen:
$22.41
24-Stunden-Volumen:
4.14M
Relative Volume:
0.86
Marktkapitalisierung:
$11.24B
Einnahmen:
$4.72B
Nettoeinkommen (Verlust:
$-232.00M
KGV:
-48.27
EPS:
-0.4663
Netto-Cashflow:
$284.00M
1W Leistung:
-1.05%
1M Leistung:
-2.64%
6M Leistung:
+1.63%
1J Leistung:
+137.70%
1-Tages-Spanne:
$22.20
$22.73
1-Wochen-Bereich:
$21.62
$22.93
52-Wochen-Spanne:
$9.42
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.51 | 11.24B | 4.72B | -232.00M | 284.00M | -0.4663 |
TAK
Takeda Pharmaceutical Co Adr
|
16.62 | 52.51B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
114.16 | 48.01B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.38 | 41.69B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.95 | 40.70B | 17.52B | 1.58B | 1.06B | 1.3428 |
UTHR
United Therapeutics Corp
|
570.40 | 24.21B | 3.18B | 1.33B | 1.04B | 27.90 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-01-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Hochstufung | Argus | Hold → Buy |
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
2,461,018 Shares in Elanco Animal Health Incorporated $ELAN Bought by Artemis Investment Management LLP - MarketBeat
MSN Money - MSN
Evaluating Elanco Animal Health (ELAN) After New Emergency Screwworm Treatment Authorizations - Yahoo Finance
Jennison Associates LLC Sells 1,347,898 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Vanguard Capital Management (ELAN) reports 26.14M shares, 5.25% stake - Stock Titan
FDA and EPA grant emergency use of Elanco screwworm treatments - Beef Magazine
Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Elanco Animal Health (ELAN) Receives a Buy from Bank of America Securities - The Globe and Mail
Elanco Animal Health (ELAN) to Release Quarterly Earnings on Wednesday - MarketBeat
Elanco Receives Emergency Authorizations for Negasunt Powder and Tanidil to Treat New World Screwworm in Livestock - iGrow News
/C O R R E C T I O N -- Elanco Animal Health/ - PR Newswire
Elanco Animal Health Incorporated $ELAN Shares Sold by Skylands Capital LLC - MarketBeat
BofA Securities Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Universal Beteiligungs und Servicegesellschaft mbH Boosts Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Veterinary care chain NVA taps Todd Young, former Acadia CFO - Stock Titan
Elanco Animal Health moves into new downtown Indianapolis headquarters - MSN
Winners And Losers Of Q4: Elanco (NYSE:ELAN) Vs The Rest Of The Pharmaceuticals Stocks - Yahoo Finance
ELAN Stock Price, Quote & Chart | ELANCO ANIMAL HEALTH INC (NYSE:ELAN) - ChartMill
Dog-Shaped Furniture Sets - Trend Hunter
Elanco Animal Health (XTER:5EA) Short-term investments - GuruFocus
Is Elanco Animal Health (ELAN) Still Attractive After A 154% One Year Share Price Surge - simplywall.st
ELAN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Elanco Animal Health Inc (ELAN) Shares Fall 4.5% -- What GF Scor - GuruFocus
Elanco (NYSE: ELAN) CEO receives new deferred stock unit grant - Stock Titan
Elanco (ELAN) CFO receives new deferred stock unit award in Form 4 filing - Stock Titan
Elanco (NYSE: ELAN) officer awarded new Deferred Stock Units grant - Stock Titan
Stifel Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Climate-neutral meat may be less than 10 years off, Elanco CEO says - Semafor
Elanco Animal Health Incorporated $ELAN Position Decreased by Davidson Investment Advisors - MarketBeat
Elanco Animal Health (NYSE:ELAN) Downgraded by Wall Street Zen to Buy - MarketBeat
174,412 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
Elanco Animal Health Price Target Announced at $30.00/Share by Citigroup - Moomoo
Citi Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement - Financial Times
Elanco Animal Health Inc (ELAN) Shares Fall 3.6% -- GF Value Says Still Overvalued - GuruFocus
ELAN Initiated Coverage by Citigroup -- Price Target Announced a - GuruFocus
Citi Initiates Elanco Animal Health(ELAN.US) With Buy Rating, Announces Target Price $30 - Moomoo
Is Elanco (ELAN) Using Mass-Market Collars to Quietly Redefine Its Companion Animal Strategy? - Yahoo Finance
Is It Too Late To Consider Elanco Animal Health (ELAN) After Its 1-Year Share Price Surge? - Yahoo Finance
Animal Health Market Intelligence Report 2026-2034 Featuring Strategic Analysis of Bayer, Elanco, Merck, Merial, Zoetis, Boehringer Ingelheim, Ceva Sante Animale, Heska and More - Yahoo Finance
Citigroup Begins Coverage on Elanco Animal Health (NYSE:ELAN) - MarketBeat
Elanco Animal Health: Leading With Innovation, Impact, and Purpose - marketscreener.com
Elanco Animal Health Incorporated (NYSE:ELAN) Short Interest Up 49.0% in March - MarketBeat
630,840 Shares in Elanco Animal Health Incorporated $ELAN Acquired by Hardman Johnston Global Advisors LLC - MarketBeat
Elanco Animal Health Inc Investor Day Transcript - GuruFocus
Q3 2025 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Institution Moves: Is Elanco Animal Health Incorporated gaining market shareEarnings Performance Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Where is Elanco Animal Health Incorporated (ELAN) headed according to the Street? - MSN
DDD Partners LLC Decreases Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Douglas Lane & Associates LLC - MarketBeat
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):